It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...

When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

Although COPD and asthma share similarities, recognising their differences is essential for accurate diagnosis and treatment.

Certain chronic conditions that affect the lungs, such as asthma and chronic obstructive pulmonary disease (COPD), can have ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

To effectively manage chronic respiratory diseases like asthma and COPD, early intervention and strict adherence to doctor ...

With unfortunately no curative therapy for chronic spontaneous urticaria (CSU) available for now, the overall goal is to ...

Needless to say that, if approved, Briquilimab will not be the first treatment available for chronic urticaria or asthma; however, tapping into those chronic disease markets is likely to result in ...

A key driver in the market’s expansion is the segment addressing severe asthma with fungal sensitization (SAFS), which is ...

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more ... (those containing ICS) reduced severe asthma exacerbations and ...